25
Jun
2026
In today’s competitive aesthetics market, standing out requires more than simply offering the latest technology. For Maharva Clinic Surabaya, success came from combining innovation, patient-centric treatments, and strategic education-Driven marketing to create a differentiated premium experience.
Founded by Dr. Aji Bayu Chandra, Maharva Clinic Surabaya is known for delivering international-standard aesthetic treatments with a focus on advanced face contouring and anti-aging solutions. As patient demand for non-invasive lifting treatments continued to rise, the clinic sought a technology that could provide strong clinical outcomes while addressing a common challenge in RF treatments: patient discomfort.
Having previously worked with premium RF devices, Dr. Chandra recognized that although treatment efficacy was often satisfactory, many patients perceived the procedures as painful or uncomfortable. This became a key factor in Maharva Clinic’s search for a next-generation RF platform that could maintain results while significantly improving the treatment experience.
That search led to XERF.
As the world’s first Dual-frequency Monopolar RF platform, XERF offered Maharva Clinic not only a clinically advanced solution, but also a unique positioning opportunity within the Surabaya aesthetic market. By becoming one of the earliest adopters of the technology in Indonesia, the clinic was able to differentiate itself from competitors offering more conventional RF treatments.
The results were immediate.
Within just three months of launching XERF, Maharva Clinic successfully sold more than 500 treatments, establishing strong patient demand and increasing visibility in the local aesthetics market.
According to Dr. Chandra, the clinic’s success was driven not only by the technology itself, but by how the treatment was communicated to patients.
“The key was not selling a treatment. The key was educating patients on the unique value that XERF brings.”
Maharva Clinic focused its messaging around the patient experience, highlighting key benefits such as no downtime, no needles, and reduced discomfort compared to traditional RF-based treatments. This patient-first communication strategy resonated strongly with consumers seeking effective yet convenient aesthetic solutions.
To further strengthen awareness, the clinic leveraged consistent digital marketing efforts across Instagram and TikTok, combining educational content, patient testimonials, and influencer collaborations to build trust and engagement. Niche micro-influencers played an important role in driving organic conversations and treatment inquiries, while press coverage and digital media exposure helped increase brand visibility and online searchability.
The clinic also positioned itself as the first adopter of Dual-frequency Monopolar RF technology in Indonesia, reinforcing its image as an innovation-led aesthetic destination.
This combination of differentiated technology, strong patient experience, and strategic digital marketing created sustained momentum for XERF at Maharva Clinic. Social media exposure and SEO-driven content continued generating ongoing inquiries, contributing to consistent treatment demand beyond the initial launch period.
For Dr. Chandra and the Maharva Clinic team, XERF aligns closely with the clinic’s long-term philosophy of delivering science-based treatments with measurable outcomes.
“XERF aligns with our commitment to science-based treatments and measurable outcomes.”
Maharva Clinic’s success highlights a growing trend in the aesthetics industry: patients increasingly seek treatments that combine visible results with comfort, convenience, and minimal disruption to daily life. By recognizing this shift early and pairing it with innovative technology and targeted education, Maharva Clinic successfully established itself as a premium lifting destination in Indonesia’s evolving aesthetic landscape.
This article is published and owned by Cynosure Lutronic APAC. All content, including text, images, graphics, and referenced materials, is intended for informational and educational purposes only.
No part of this publication may be reproduced, republished, distributed, transmitted, modified, or used in any form without prior written permission from Cynosure Lutronic APAC. Limited excerpts may be shared for non-commercial purposes with proper attribution to Cynosure Lutronic APAC and inclusion of the original source link where applicable.
The views, experiences, and results shared in this article are based on individual clinic experiences and may vary depending on patient condition, treatment protocol, and practitioner expertise. This content does not constitute medical advice or guarantee specific clinical outcomes.
For media inquiries, republication requests, or additional information, please contact: [email protected]
© 2026 Cynosure Lutronic APAC. All rights reserved.